News

New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed this way. By Teddy Rosenbluth The Department of Health and Human ...
But researchers are pressing ahead with new clinical trials for more targeted treatments built on advances in our understanding of long covid. There’s now a large body of research on the condition.
A Chinese startup has opened the world’s first clinic in Saudi Arabia where artificial intelligence diagnoses patients, a key step in replacing human doctors as the first line of medical treatment.
The Food and Drug Administration's approval in 2023 of lecanemab—a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression—was met with enthusiasm by many in ...
Clinical trials to test vaccine against Alzheimer's-promoting tau protein. ScienceDaily . Retrieved June 3, 2025 from www.sciencedaily.com / releases / 2025 / 04 / 250423164249.htm ...
GameSpot may get a commission from retail offers. The Outlast Trials' next major update is coming on April 22, and with it comes the game's first foray into user-generated content (UGC).
A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment expected in September. A phase 2a clinical trial of NEO100-01 is continuing to ...
Clinical-stage drug development offers big rewards—and big risks. To that end, Fierce Biotech recently published its annual roundup of several of the most eye-catching trial failures of the ...
While laying out her options to fight the cancer, he mentioned that he was running a clinical trial that he believed she would be the "perfect candidate" for. The trial would combine standard ...
The U.S. Food and Drug Administration recently approved the first-ever clinical trial of the transplantation of a nonhuman animal organ—a genetically modified pig kidney—into living human ...
CHICAGO, Jan 24 (Reuters) - The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and devices in diverse populations as part of a ...
A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The announcement comes as artificial ...